Literature DB >> 8677913

Assessing quality of life in patients with cancer: a comparison of a visual-analogue and a categorical model.

F Giorgi1, R Cellerino, A Gramazio, D Tummarello, E T Menichetti, P Giordani, S Antognoli, F Carle, A Piga.   

Abstract

A simple instrument for self-assessment of quality of life (QL) in patients with cancer was elaborated using a linear analogue scale (LAS). The instrument was based on five questions, exploring different functional areas; the same questions were also addressed in a parallel format, where problems were seen from an opposite point of view (positive/negative). The LAS was given to 222 patients, for a total of 372 tests collected. Internal consistency was satisfactory (Cronbach's alpha = 0.75); QL score was significantly correlated to parameters of disease. Concordance between scales, as judged by comparison of parallel formats, was statistically significant but poor. A questionnaire was then elaborated with similar items, based on a categorical scale. A direct comparison between LAS and our questionnaire was made on a group of 41 patients. Internal consistency was poor for the LAS (alpha = 0.58) and good for the questionnaire (alpha = 0.93); Spearman's rank correlation coefficients were disappointing for the LAS and good for the questionnaire; the questionnaire was judged reliable in 82.9% of cases, the LAS in 29.3% only; the questionnaire score, and not the LAS score, was significantly correlated with PS and disease status. In conclusion, many patients appeared unable to correctly interpret the visual-analogue scale; the categorical scale was more immediate and correctly understood by the large majority of patients; the correlation between score and important parameters of QL was maintained, and internal consistency was excellent, indicating a satisfactory reliability of this instrument.

Entities:  

Mesh:

Year:  1996        PMID: 8677913     DOI: 10.1097/00000421-199608000-00016

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  9 in total

Review 1.  A systematic review of measures of end-of-life care and its outcomes.

Authors:  Richard A Mularski; Sydney M Dy; Lisa R Shugarman; Anne M Wilkinson; Joanne Lynn; Paul G Shekelle; Sally C Morton; Virginia C Sun; Ronda G Hughes; Lara K Hilton; Margaret Maglione; Shannon L Rhodes; Cony Rolon; Karl A Lorenz
Journal:  Health Serv Res       Date:  2007-10       Impact factor: 3.402

2.  Edmonton symptom assessment scale: Italian validation in two palliative care settings.

Authors:  Cecilia Moro; Cinzia Brunelli; Guido Miccinesi; Mauro Fallai; Piero Morino; Massimo Piazza; Roberto Labianca; Carla Ripamonti
Journal:  Support Care Cancer       Date:  2005-06-04       Impact factor: 3.603

3.  Evaluation of the treatment of chronic chemotherapy-induced peripheral neuropathy using long-wave diathermy and interferential currents: a randomized controlled trial.

Authors:  Katarina Lindblad; Leif Bergkvist; Ann-Christin Johansson
Journal:  Support Care Cancer       Date:  2015-12-21       Impact factor: 3.603

4.  Relationship between deficits in overall quality of life and non-small-cell lung cancer survival.

Authors:  Jeff A Sloan; Xinghua Zhao; Paul J Novotny; Jason Wampfler; Yolanda Garces; Matthew M Clark; Ping Yang
Journal:  J Clin Oncol       Date:  2012-03-26       Impact factor: 44.544

5.  Global Quality of Life Among WHI Women Aged 80 Years and Older.

Authors:  Michelle J Naughton; Robert L Brunner; Patricia E Hogan; Suzanne C Danhauer; Gretchen A Brenes; Deborah J Bowen; Beverly M Snively; Joseph S Goveas; Nazmus Saquib; Oleg Zaslavsky; Sally A Shumaker
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-03       Impact factor: 6.053

6.  Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance).

Authors:  Tufia C Haddad; Jun He; Ciara C O'Sullivan; Beiyun Chen; Donald Northfelt; Amylou C Dueck; Karla V Ballman; Kathleen S Tenner; Hannah Linden; Joseph A Sparano; Judith O Hopkins; Chamath De Silva; Edith A Perez; Paul Haluska; Matthew P Goetz
Journal:  Breast Cancer Res Treat       Date:  2021-04-14       Impact factor: 4.872

7.  The effectiveness and safety of acupuncture for chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis.

Authors:  Zhonghang Xu; Xingbo Wang; Yuanyu Wu; Chengbing Wang; Xuedong Fang
Journal:  Front Neurol       Date:  2022-10-03       Impact factor: 4.086

8.  Electroacupuncture for chemotherapy-induced peripheral neuropathy: study protocol for a pilot multicentre randomized, patient-assessor-blinded, controlled trial.

Authors:  Joo-Hee Kim; Eun-Jung Kim; Byung-Kwan Seo; Sanghun Lee; Seunghoon Lee; So-Young Jung; Min-Hee Lee; Ae-Ran Kim; Hyo-Ju Park; Mi-Suk Shin; Sun-Mi Choi
Journal:  Trials       Date:  2013-08-14       Impact factor: 2.279

9.  Impact of self-reported physical activity and health promotion behaviors on lung cancer survivorship.

Authors:  Jeff A Sloan; Andrea L Cheville; Heshan Liu; Paul J Novotny; Jason A Wampfler; Yolanda I Garces; Matthew M Clark; Ping Yang
Journal:  Health Qual Life Outcomes       Date:  2016-04-29       Impact factor: 3.186

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.